Zimmer Biomet Announces First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Zimmer Biomet (ZBH) PT Lowered to $130 at RBC Capital
April 27, 2018 9:02 AM EDTRBC Capital lowered its price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $140.00) while maintaining a Outperform rating.
... MoreZimmer Biomet (ZBH) PT Lowered to $146 at Needham & Company
April 27, 2018 6:28 AM EDTNeedham & Company lowered its price target on Zimmer Biomet (NYSE: ZBH) to $146.00 (from $155.00) while maintaining a Strong Buy rating.
Analyst Mike Matson commented, "ZBH's 1Q18 revenue and EPS beat consensus. Management's 2018 revenue guidance was above consensus while its EPS guidance was slightly below... More
Zimmer Biomet (ZBH) PT Lowered to $130 at Jefferies; 'Putting in the Bottom?'
April 26, 2018 1:44 PM EDTJefferies lowered its price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $141.00) while maintaining a Buy rating.
... MoreZimmer Biomet (ZBH) PT Lowered to $137 at BMO Capital; 'Making Very Early Progress, Resetting the Bar'
April 26, 2018 1:17 PM EDTBMO Capital lowered its price target on Zimmer Biomet (NYSE: ZBH) to $137.00 (from $144.00) while maintaining a Outperform rating.
... MoreZimmer Biomet (ZBH) PT Raised to $117.50 at Evercore ISI
April 26, 2018 1:05 PM EDTEvercore ISI raised its price target on Zimmer Biomet (NYSE: ZBH) to $117.50 (from $115.00) while maintaining a In Line rating.
What analsyt Vijay Kumar liked:
Management is confident on the supply recovery turnaround in July that will help accelerate sales growth... More